Sean Carrick - 30 Jun 2021 Form 4 Insider Report for Nascent Biotech Inc.

Role
President & CEO, Director, 10%+ Owner
Signature
/s/ Sean Carrick
Issuer symbol
NBIO on OTC
Transactions as of
30 Jun 2021
Net transactions value
+$36,477
Form type
4
Filing time
08 Feb 2022, 16:06:59 UTC
Next filing
04 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBIO Common Stock Other $36,477 +347,400 +2.2% $0.1050* 16,021,131 30 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as part of the employment contract with the Company.